You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Pilot Study of be Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
- Disease
- autoimmune diseases
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Jan 3, 2007
- Study Name
- C-935788-007
- Study Id
- D4300C00022
- ClinicalTrials.gov ID
- NCT00706342
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
